Skip to main content
GYRE logo

GYRE · Gyre Therapeutics, Inc.

Track GYRE — free
$6.86 +0.42 (+6.52%) At close · Sep 4
Market Cap
$714.78M
Shares
111.51M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 68 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1124105 CUSIP 403783103 13F (30d) 45 filings 45 filers Visit website Investor relations